Quthero, Inc.

quthero’s patented platform technology harnesses the power of regenerative healing to develop single-dose topical treatments for chronic wounds and injectable therapies for cardiovascular diseases. our approach is based on a new patented molecule that uniquely acts to promote hallmarks of complete tissue regeneration and wound healing. simply speaking, our technology prompts the cells to repair tissues and close the wounds quickly and efficiently, activating the same mechanisms that are at play during development and in highly regenerative organisms. our unique regenerative therapies activate these mechanisms in a new, highly potent, paradigm-shifting way – they are effective in a single dose at a nanomol-concentration. efficacy has been demonstrated in multiple preclinical models and cell/tissue types including cardiovascular, endothelial, cutaneous tissue, osteoblasts and hipsc. this novel protective therapy is highly potent and easy to manufacture.